Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-354-3 | CAS number: 1323-39-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Stearic acid, monoester with propane-1,2-diol (PGMS) is a UVCB substance. The two main constituents of the UVCB substance are the monoester of propane-diol with octadecanoic acid (45-98%) and the monoester of propane-diol with palmitic acid (2-50%).
Metabolism studies of propane-1,2-diol esters of stearate show that the substances are partially hydrolysed by pancreatic lipase; approx. 70% in 15 h. As the passage through the small intestine has a duration of 6–8 h, unhydrolyzed propane-1,2-diol esters of stearate will be present in the gastrointestinal tract for absorption (EFSA 2018a).
The possible repeated dose toxicity of this substance is therefore assessed in the present weight of evidence analysis based on existing data on propane-1,2-diol esters of fatty acids including PGMS (EFSA 2018a) and the relevant hydrolysis products propane-1,2-diol (EFSA 2018b) and fatty propylene glycol stearate (PGS) and glycerol stearate (CIR 2015; 2016).
Three studies on PGMS are reported for repeated dose toxicity. Two 90-day studies in rats exposed to PGMS via the diet at concentrations up to 6768 mg PGMS /kg bw per day was conducted. Animals were examined for differences in organ weights, gross and microscopic pathology, haematology and urinalysis. No clinical symptoms or treatment related effects were found. The NOAEL based on these studies is therefore the highest dose tested; ≥ 6768 mg/kg bw/day (EFSA 2018).
No treatment-related effects were detected in the Beagle dog exposed for 6 months via the diet containing up to 432 mg PGMS/kg bw/day (King et al., 1971 in EFSA 2018).
Supportive of this, no evidence of oral or dermal toxicity was found in subchronic studies of animals exposed to propylene glycol monostearate in rats and dogs (CIR 2015). No toxicity was reported in subchronic and chronic dermal toxicity tests, 4-5% GS in rabbits, other than local effects of moderate irritation (CIR 2016).
Further, it is noted that PGS and GS is considered Generally Recognized as Safe (GRAS) for food use (CIR 2015; 2016).
Also, data on propane 1,2-diol did not show any adverse effects of propane 1,2-diol, for which an ADI of 25 mg/kg bw/day could be established by EFSA (2018b).
Based on the available studies on PGMS and the propylene glycol esters described above, it can from an overall weight of evidence approach be concluded that the UVCB substance PGMS is of very low concern for repeated dose toxicity. It can with a high degree of confidence be concluded that an assumed NOAEL for PGMS is far above 1000 mg/kg bw/day, which is normally considered as the highest relevant dose level when testing for repeated dose toxicity.
Overall, the available information comprises adequate, reliable studies from reference substances with similar structure and intrinsic properties. Weight-of-evidence is justified based on common functional group and common precursors/breakdown products. The information from these independent sources is consistent and provides sufficient weight of evidence leading to an endpoint conclusion in accordance with Annex XI, 1.2, of Regulation (EC) No 1907/2006.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- other: Weight of evidence analysis based on expert reviews on hydrolysis products and structural analogues
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: based on expert group reviews
- Justification for type of information:
- Stearic acid, monoester with propane-1,2-diol (PGMS) is manufactured by a reaction between stearic acid and propylene glycol. The UVCB substance belongs to the group of fatty acid esters.
Within this group is the group of polyglycerol fatty acid esters, which are commonly used in cosmetics and as food ingredients representing substances composed of chemical units of similar structure as the fatty acid esters with propylene glycol. The polyglycerol fatty acids are esters of fatty acids and units of glycerol. The glycerol units represent the propylene glycol in “Stearic acid, monoester with propane-1,2-diol”.
To assess the repeated dose toxicity of the UVCB substance, the toxicity of polyglyceryl fatty acid esters in general is therefore considered.
Further, Stearic acid, monoester with propane-1,2-diol (PGMS) is a UVCB substance. The two main constituents of the UVCB substance are the monoester of propane-diol with octadecanoic acid (45-98%) and the monoester of propane-diol with palmitic acid (2-50%).
Detailed study reports on this endpoint is not available for “Stearic acid, monoester with propane-1,2-diol (PGMS)”, however data on PGMS in expert reviews are available. Further, existing data on propylene glycol stearate (PGS) and glycerol stearate (CIR 2015; 2016) is used as support.
In general, data from the following expert assessments are used in a weight of evidence approach:
CIR (2015). Safety Assessment of Propylene Glycol Esters as Used in Cosmetics, Final Amended report, January 15, 2015
CIR (2016). Safety Assessment of Monoglyceryl Monoesters as Used in Cosmetics, Final Amended report, January 15, 2016
EFSA (2018a). Re-evaluation of propane-1,2-diol esters of fatty acids (E 477) as a food additive EFSA Panel on Food Additives and Flavourings (FAF). EFSA Journal 2018;16(12):5497.
EFSA (2018b). Re-evaluation of propane-1,2-diol (E 1520) as a food additive EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). EFSA Journal 2018;16(4):5235 - Principles of method if other than guideline:
- In relation to the data requirements of REACH VIII (10-100 t/y), data on repeated dose toxicity must be provided. Detailed study reports on this endpoint is not available for Stearic acid, monoester with propane-1,2-diol (PGMS), however data on PGMS in expert reviews are available.
Metabolism studies of propane-1,2-diol esters of stearate show that the substances are partially hydrolysed by pancreatic lipase; approx. 70% in 15 h. As the passage through the small intestine has a duration of 6–8 h, unhydrolyzed propane-1,2-diol esters of stearate will be present in the gastrointestinal tract for absorption (EFSA 2018a).
The possible repeated dose toxicity of this substance is therefore assessed in the present weight of evidence analysis based on existing data on propane-1,2-diol esters of fatty acids including PGMS (EFSA 2018a) and the relevant hydrolysis products propane-1,2-diol (EFSA 2018b) and fatty propylene glycol stearate (PGS) and glycerol stearate (CIR 2015; 2016).
As the substance is an UVCB-substance and as the EFSA expert group assessments of the substance is considered the most valid data for the assessment, an overall weight of evidence approach is used for the assessment. - Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day (nominal)
- Basis for effect level:
- other: Collection of relevant data. Please see attached document
- Critical effects observed:
- no
- Conclusions:
- Based on the available studies on Stearic acid, monoester with propane-1,2-diol (PGMS) and supportive data on propylene glycol stearate (PGS) and glycerol stearate (GS), it can from an overall weight of evidence approach be concluded that the UVCB substance PGMS is of very low concern for repeated dose toxicity. It can with a high degree of confidence be concluded that an assumed NOAEL is far above 1000 mg/kg bw/day, which is normally considered as the highest relevant dose level when testing for repeated dose toxicity. Thus, no STOT RE classification should apply for PGMS.
Overall, available information comprises adequate, reliable studies from
reference substances with similar structure and intrinsic properties. Using data
from comparable substances is justified based on common functional group,
common precursors/breakdown products. The information from these
independent sources is consistent and provides sufficient weight of evidence
leading to an endpoint conclusion in accordance with Annex XI, 1.2, of
Regulation (EC) No 1907/2006. - Executive summary:
Stearic acid, monoester with propane-1,2-diol (PGMS) is a UVCB substance. The two main constituents of the UVCB substance are the monoester of propane-diol with octadecanoic acid (45-98%) and the monoester of propane-diol with palmitic acid (2-50%). Detailed study reports on this endpoint is not available for PGMS, however data on PGMS in expert reviews are available. Further, existing data on propylene glycol stearate (PGS) and glycerol stearate (GS) (CIR 2015; 2016) are used as support.
Three studies on PGMS are reported for repeated dose toxicity. Two 90-day studies in rats exposed to PGMS via the diet at concentrations up to 6768 mg PGMS /kg bw per day was conducted. Animals were examined for differences in organ weights, gross and microscopic pathology, haematology and urinalysis. No clinical symptoms or treatment related effects were found. The NOAEL based on these studies is therefore the highest dose tested; ≥ 6768 mg/kg bw/day (EFSA 2018).
No treatment-related effects were detected in the Beagle dog exposed for 6 months via the diet containing up to 432 mg PGMS/kg bw/day (King et al., 1971 in EFSA 2018).
Supportive of this, no evidence of oral or dermal toxicity was found in subchronic studies of animals exposed to propylene glycol monostearate in rats and dogs (CIR 2015). No toxicity was reported in subchronic and chronic dermal toxicity tests, 4-5% GS in rabbits, other than local effects of moderate irritation (CIR 2016).
Further, it is noted that PGS and GS is considered Generally Recognized as Safe (GRAS) for food use (CIR 2015; 2016).
Also, data on propane 1,2-diol did not show any adverse effects of propane 1,2-diol, for which an ADI of 25 mg/kg bw/day could be established by EFSA (2018b).
Based on the available studies on PGMS and the propylene glycol esters described above, it can from an overall weight of evidence approach be concluded that the UVCB substance PGMS is of very low concern for repeated dose toxicity. It can with a high degree of confidence be concluded that an assumed NOAEL for PGMS is far above 1000 mg/kg bw/day, which is normally considered as the highest relevant dose level when testing for repeated dose toxicity. Thus, no STOT RE classification should apply for the substance.
Overall, available information comprises adequate, reliable studies from reference substances with similar structure and intrinsic properties. Using data from comparable substances is justified based on common functional group, common precursors/breakdown products. The information from these independent sources is consistent and provides sufficient weight of evidence leading to an endpoint conclusion in accordance with Annex XI, 1.2, of Regulation (EC) No 1907/2006.
Reference
Propane-1,2-diol esters of fatty acids are listed as a food additive (E 477) and has been re-evaluated by EFSA in 2018 (EFSA 2018). The Scientific Committee on Food (SCF) endorsed the acceptable daily intake (ADI) of 25 mg/kg bw/day established by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in 1974 (EFSA 2018)
Three studies on PGMS are reported for repeated dose toxicity. In a 13-week study, rats were exposed to PGMS via the diet containing 0%, 1.5%, 3.36% or 7.52% of PGMS (equivalent to 0, 1350, 3024 or 6768 mg/kg bw per day (Brandner, 1973 in EFSA 2018). At termination of the study, measurements of relative organ weights, histopathology, clinical chemistry and urinary analyses showed no treatment related difference between the groups.
The NOAEL identified in this study was therefore the highest dose tested; 6768 mg/kg bw/day (EFSA 2018a).
In a 90-day study in Sprague–Dawley rats received a diet containing 2.5%, 5% or 10% succistearin 14 (equivalent to 0, 390, 780 or 1,560 mg PGMS/kg bw/day); the control group was fed with soybean oil (King et al., 1971 in EFSA 2108a). The total fat content in each diet was 21%. No clinical symptoms were observed and no effects on body weight gain. Haematology, urinalysis and comparison of organ weight data revealed no treatment related effects as well as gross and microscopic pathology (EFSA 2018a).
Finally, a study in Beagle dogs is reported. The dogs were exposed for 6 months via the diet containing 0%, 5% or 10% succistearin (17.3% of PGMS) (equivalent to 0, 216 or 432 mg PGMS/kg bw/day); the control group was fed with soybean oil (King et al., 1971 in EFSA 2018). No treatment-related effects were detected in the Beagle dogs (EFSA 2018a).
Further, The safety of propylene glycol esters was reviewed by Cosmetic Ingredient Review (CIR) Expert Panel for the use in cosmetic products (CIR 2015). Propylene Glycol Stearate (PGS) is a mixture of the mono- and diesters of triple-pressed stearic acid and propylene glycol and data on repeated dose toxicity is included in the review. No detailed information is available, but it is stated that no evidence of oral or dermal toxicity was found in subchronic animal studies. A chronic six-month feeding study showed no signs of toxicity when a mixture containing 17% propylene glycol monostearate was incorporated at 10% into the diets of rats and dogs (CIR 2015).
The safety of monoglyceryl monoesters was also reviewed by CIR (CIR 2016) with a similar conclusion. No toxicity was reported in subchronic and chronic dermal toxicity tests, 4-5% Glyceryl Stearate (GS) in rabbits, other than local effects of moderate irritation (CIR 2016).
Further, it is noted that PGS and GS is considered Generally Recognized as Safe (GRAS) for food use (CIR 2015; 2016).
In support, Data on the repeated dose toxicity of propane 1,2-diol is available from a recent EFSA evaluation (2018b). Based on a large data package on short-term and subchronic toxicity, EFSA concluded that no treatment-related effects were observed in subchronic toxicity in rat, mice, rabbit. Further, no adverse effects
were reported in a 2-year chronic study in rats with propane-1,2-diol (up to 2500 mg/kg bw per day). Also, data from gavage studies using mice, rats and monkeys and dogs, did not show any repeated dose toxicity using 1000 mg/kg bw/day. Overall, EFSA (2018b) concluded no adverse effects of propane 1,2-
diol and that an ADI of 25 mg/kg bw/day could be established.
Based on the available studies on PGMS and the propylene glycol esters described above as well as propane 1,2-diol, it can from an overall weight of evidence approach be concluded that the UVCB substance Stearic acid, monoester with propane-1,2-diol (PGMS) is of very low concern for repeated dose toxicity. It can with a high degree of confidence be concluded that an assumed NOAEL for PGMS is far above 1000 mg/kg bw/day, which is normally considered as the highest relevant dose level when testing for repeated dose toxicity. Thus, no STOT RE classification should apply for the substance (PGMS).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the available studies on Stearic acid, monoester with propane-1,2-diol (PGMS) and supportive data on propylene glycol stearate (PGS) and glycerol stearate (GS), it is concluded that an assumed NOAEL is far above 1000 mg/kg bw/day, which is normally considered as the highest relevant dose level when testing for repeated dose toxicity. Thus, no STOT RE classification should apply for PGMS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.